A “Good” Smoke? The Off-Label Use of Cannabidiol to Reduce Cannabis Use

Fortin, Davide; Di Beo, Vincent; Massin, Sophie; Bisiou, Yann; Carrieri, Patrizia; Barré, Tangui

Document type :

Compte-rendu et recension critique d'ouvrage

DOI :

10.3389/fpsyt.2022.829944

PMID :

35370865

Title :

A “Good” Smoke? The Off-Label Use of Cannabidiol to Reduce Cannabis Use

Author(s) :

Fortin, Davide [Auteur]
Université Paris 1 Panthéon-Sorbonne [UP1]
Di Beo, Vincent [Auteur]
Sciences Economiques et Sociales de la Santé & Traitement de l'Information Médicale [SESSTIM - U1252 INSERM - Aix Marseille Univ - UMR 259 IRD]
Institut des sciences de la santé publique [Marseille] [ISSPAM]
Massin, Sophie [Auteur]
Lille économie management - UMR 9221 [LEM]
Bisiou, Yann [Auteur]
Communication, Ressources Humaines et Intervention Sociale [CORHIS]
Carrieri, Patrizia [Auteur]
Sciences Economiques et Sociales de la Santé & Traitement de l'Information Médicale [SESSTIM - U1252 INSERM - Aix Marseille Univ - UMR 259 IRD]
Institut des sciences de la santé publique [Marseille] [ISSPAM]
Barré, Tangui [Auteur]
Sciences Economiques et Sociales de la Santé & Traitement de l'Information Médicale [SESSTIM - U1252 INSERM - Aix Marseille Univ - UMR 259 IRD]
Institut des sciences de la santé publique [Marseille] [ISSPAM]

Journal title :

Frontiers in Psychiatry

Pages :

829944

Publisher :

Frontiers

Publication date :

2022-03-17

ISSN :

1664-0640

English keyword(s) :

cannabidiol (CBD)
cannabis (marijuana)
cannabis use disorder (CUD)
smoking
France
harm reduction

HAL domain(s) :

Sciences de l'Homme et Société/Economies et finances

English abstract : [en]

Although cannabis use is common in France, it is still criminalized. Cannabidiol (CBD) products, including CBD-rich cannabis, are legally available. Although previous results suggested that CBD may have benefits for people ...
Show more >Although cannabis use is common in France, it is still criminalized. Cannabidiol (CBD) products, including CBD-rich cannabis, are legally available. Although previous results suggested that CBD may have benefits for people with cannabis use disorder, there is a lack of data on cannabis users who use CBD to reduce their cannabis consumption. We aimed to identify (i) correlates of this motive, and (ii) factors associated with successful attempts to reduce cannabis use. Methods A cross-sectional online survey among French-speaking CBD and cannabis users was conducted. Logistic regressions were performed to identify correlates of using CBD to reduce cannabis consumption and correlates of reporting a large reduction. Results Eleven percent ( n = 105) of our study sample reported they primarily used CBD to reduce cannabis consumption. Associated factors included smoking tobacco cigarettes (adjusted odds ratio (aOR) [95% confidence interval (CI)] 2.17 [1.3–3.62], p = 0.003) and drinking alcohol (aOR [95%CI] 1.8 [1.02–3.18], p = 0.042). Of these 105, 83% used CBD-rich cannabis to smoke, and 58.7% reported a large reduction in cannabis consumption. This large reduction was associated with non-daily cannabis use (aOR [95%CI] 7.14 [2.4–20.0], p < 0.001) and daily CBD use (aOR [95%CI] 5.87 [2.09–16.47], p = 0.001). A reduction in cannabis withdrawal symptoms thanks to CBD use was the most-cited effect at play in self-observed cannabis reduction. Conclusions Cannabis use reduction is a reported motive for CBD use—especially CBD-rich cannabis to smoke—in France. More studies are needed to explore practices associated with this motive and to accurately assess CBD effectiveness.Show less >

Language :

Anglais

Popular science :

Non

Collections :